Last reviewed · How we verify
Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel (Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel) — Massachusetts General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel TARGET | Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel | Massachusetts General Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel CI watch — RSS
- Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel CI watch — Atom
- Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel CI watch — JSON
- Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel alone — RSS
Cite this brief
Drug Landscape (2026). Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/clindamycin-phosphate-1-2-and-tretinoin-0-025-gel. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab